1. Home
  2. HITI vs TVGN Comparison

HITI vs TVGN Comparison

Compare HITI & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo High Tide Inc.

HITI

High Tide Inc.

HOLD

Current Price

$2.33

Market Cap

189.8M

Sector

N/A

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

N/A

Current Price

$6.58

Market Cap

21.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
HITI
TVGN
Founded
2009
2020
Country
Canada
United States
Employees
N/A
N/A
Industry
Blank Checks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
189.8M
21.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
HITI
TVGN
Price
$2.33
$6.58
Analyst Decision
Strong Buy
Hold
Analyst Count
2
1
Target Price
$6.13
N/A
AVG Volume (30 Days)
334.0K
10.9K
Earning Date
06-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.73
N/A
Revenue Next Year
$12.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.02
$0.14
52 Week High
$4.06
$12.03

Technical Indicators

Market Signals
Indicator
HITI
TVGN
Relative Strength Index (RSI) 60.09 53.59
Support Level $2.20 $6.33
Resistance Level $2.40 $7.42
Average True Range (ATR) 0.08 0.69
MACD 0.03 0.15
Stochastic Oscillator 77.22 70.40

Price Performance

Historical Comparison
HITI
TVGN

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: